The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin - PubMed (original) (raw)
C Barbot, N Tachi, N Kozuka, E Uchida, T Gibson, P Mendonça, M Costa, J Barros, T Yanagisawa, M Watanabe, Y Ikeda, M Aoki, T Nagata, P Coutinho, J Sequeiros, M Koenig
Affiliations
- PMID: 11586300
- DOI: 10.1038/ng1001-189
The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin
M C Moreira et al. Nat Genet. 2001 Oct.
Abstract
The newly recognized ataxia-ocular apraxia 1 (AOA1; MIM 208920) is the most frequent cause of autosomal recessive ataxia in Japan and is second only to Friedreich ataxia in Portugal. It shares several neurological features with ataxia-telangiectasia, including early onset ataxia, oculomotor apraxia and cerebellar atrophy, but does not share its extraneurological features (immune deficiency, chromosomal instability and hypersensitivity to X-rays). AOA1 is also characterized by axonal motor neuropathy and the later decrease of serum albumin levels and elevation of total cholesterol. We have identified the gene causing AOA1 and the major Portuguese and Japanese mutations. This gene encodes a new, ubiquitously expressed protein that we named aprataxin. This protein is composed of three domains that share distant homology with the amino-terminal domain of polynucleotide kinase 3'- phosphatase (PNKP), with histidine-triad (HIT) proteins and with DNA-binding C2H2 zinc-finger proteins, respectively. PNKP is involved in DNA single-strand break repair (SSBR) following exposure to ionizing radiation and reactive oxygen species. Fragile-HIT proteins (FHIT) cleave diadenosine tetraphosphate, which is potentially produced during activation of the SSBR complex. The results suggest that aprataxin is a nuclear protein with a role in DNA repair reminiscent of the function of the protein defective in ataxia-telangiectasia, but that would cause a phenotype restricted to neurological signs when mutant.
Similar articles
- Early-onset ataxia with ocular motor apraxia and hypoalbuminemia is caused by mutations in a new HIT superfamily gene.
Date H, Onodera O, Tanaka H, Iwabuchi K, Uekawa K, Igarashi S, Koike R, Hiroi T, Yuasa T, Awaya Y, Sakai T, Takahashi T, Nagatomo H, Sekijima Y, Kawachi I, Takiyama Y, Nishizawa M, Fukuhara N, Saito K, Sugano S, Tsuji S. Date H, et al. Nat Genet. 2001 Oct;29(2):184-8. doi: 10.1038/ng1001-184. Nat Genet. 2001. PMID: 11586299 - Early-onset ataxia with oculomotor apraxia with a novel APTX mutation.
Ito A, Yamagata T, Mori M, Momoi MY. Ito A, et al. Pediatr Neurol. 2005 Jul;33(1):53-6. doi: 10.1016/j.pediatrneurol.2005.01.012. Pediatr Neurol. 2005. PMID: 15876520 - Aprataxin, a novel protein that protects against genotoxic stress.
Gueven N, Becherel OJ, Kijas AW, Chen P, Howe O, Rudolph JH, Gatti R, Date H, Onodera O, Taucher-Scholz G, Lavin MF. Gueven N, et al. Hum Mol Genet. 2004 May 15;13(10):1081-93. doi: 10.1093/hmg/ddh122. Epub 2004 Mar 25. Hum Mol Genet. 2004. PMID: 15044383 - Short-patch single-strand break repair in ataxia oculomotor apraxia-1.
Reynolds JJ, El-Khamisy SF, Caldecott KW. Reynolds JJ, et al. Biochem Soc Trans. 2009 Jun;37(Pt 3):577-81. doi: 10.1042/BST0370577. Biochem Soc Trans. 2009. PMID: 19442253 Review. - Defective DNA repair and neurodegenerative disease.
Rass U, Ahel I, West SC. Rass U, et al. Cell. 2007 Sep 21;130(6):991-1004. doi: 10.1016/j.cell.2007.08.043. Cell. 2007. PMID: 17889645 Review.
Cited by
- Poly ADP-ribose signaling is dysregulated in Huntington disease.
Maiuri T, Bazan CB, Harding RJ, Begeja N, Kam TI, Byrne LM, Rodrigues FB, Warner MM, Neuman K, Mansoor M, Badiee M, Dasovich M, Wang K, Thompson LM, Leung AKL, Andres SN, Wild EJ, Dawson TM, Dawson VL, Arrowsmith CH, Truant R. Maiuri T, et al. Proc Natl Acad Sci U S A. 2024 Oct;121(40):e2318098121. doi: 10.1073/pnas.2318098121. Epub 2024 Sep 27. Proc Natl Acad Sci U S A. 2024. PMID: 39331414 - PQBP3 prevents senescence by suppressing PSME3-mediated proteasomal Lamin B1 degradation.
Yoshioka Y, Huang Y, Jin X, Ngo KX, Kumaki T, Jin M, Toyoda S, Takayama S, Inotsume M, Fujita K, Homma H, Ando T, Tanaka H, Okazawa H. Yoshioka Y, et al. EMBO J. 2024 Sep;43(18):3968-3999. doi: 10.1038/s44318-024-00192-4. Epub 2024 Aug 5. EMBO J. 2024. PMID: 39103492 Free PMC article. - A Novel Compound Heterozygous Mutation in Aprataxin Causes Slowly Progressive Ataxia without Oculomotor Apraxia.
Satolli S, De Micco R, Galatolo D, Tessa A, Cirillo M, Tessitore A, Santorelli FM. Satolli S, et al. Mov Disord Clin Pract. 2024 Sep;11(9):1156-1159. doi: 10.1002/mdc3.14132. Epub 2024 Jun 16. Mov Disord Clin Pract. 2024. PMID: 38881152 No abstract available. - The DNA repair enzyme, aprataxin, plays a role in innate immune signaling.
Madsen HB, Pease LI, Scanlan RL, Akbari M, Rasmussen LJ, Shanley DP, Bohr VA. Madsen HB, et al. Front Aging Neurosci. 2023 Dec 15;15:1290681. doi: 10.3389/fnagi.2023.1290681. eCollection 2023. Front Aging Neurosci. 2023. PMID: 38161589 Free PMC article. - Genetic Investigation of Consanguineous Pakistani Families Segregating Rare Spinocerebellar Disorders.
Saadi SM, Cali E, Khalid LB, Yousaf H, Zafar G, Khan HN, Sher M, Vona B, Abdullah U, Malik NA, Klar J, Efthymiou S, Dahl N, Houlden H, Toft M, Baig SM, Fatima A, Iqbal Z. Saadi SM, et al. Genes (Basel). 2023 Jul 6;14(7):1404. doi: 10.3390/genes14071404. Genes (Basel). 2023. PMID: 37510308 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases